Telehealth Treatment for Substance Use Disorders
Author Information
Author(s): Joanna Contreras-Schwartz, Conor O’Neill, Annelise Threlkeld, Erin O’Callaghan, Mirene Winsberg, Carlos Laranjeira, Ana Querido, John H. Foster
Primary Institution: Brightside Health
Hypothesis
This study aims to explore the feasibility of providing a telehealth intensive outpatient program (IOP) for substance use disorders (SUDs).
Conclusion
The study supports the feasibility and effectiveness of delivering a telehealth IOP for SUDs, with high rates of participant engagement and abstinence.
Supporting Evidence
- Nearly 80% of participants remained engaged in the program for 30 days.
- 91% attained at least 30 consecutive days of abstinence over the course of treatment.
- Nearly 45% demonstrated a successful response to care and no longer required IOP treatment.
Takeaway
This study shows that people can get help for substance use problems through online programs, and many stay engaged and sober.
Methodology
The study analyzed existing records from participants enrolled in a telehealth IOP for SUDs between 2021 and 2023.
Potential Biases
Self-reported abstinence may introduce bias, and the sample may not represent all demographics of SUD patients.
Limitations
The study relied on archival data, which limited the ability to analyze long-term recovery outcomes and reasons for disengagement.
Participant Demographics
Participants were mostly white (79.42%), with a mean age of 42, and included 49.09% males and 46.04% females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website